Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
918.52
-2.97 (-0.32%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
98
99
Next >
Eli Lilly Snaps Up Morphic At 79% Premium
July 08, 2024
Eli Lilly said Monday it would pay $3.2 billion to acquire an innovator in oral treatments for chronic bowel diseases.
Via
Investor's Business Daily
3 No-Brainer Stocks to Buy in July
July 08, 2024
Investors shouldn't have to think too hard about these great stocks.
Via
The Motley Fool
The Next $1 Trillion Stock? Tesla, Warren Buffett's Berkshire Hathaway In The Running
July 08, 2024
Tesla, Warren Buffett's Berkshire Hathaway are close, but this is No.1.
Via
Investor's Business Daily
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs.
Via
Benzinga
Topics
ETFs
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now.
Via
InvestorPlace
What's Going On With Eli Lilly Shares Friday?
July 05, 2024
Eli Lilly and Co. (NYSE: LLY) shares are experiencing increased activity Friday afternoon. Here's what you need to know.
Via
Benzinga
Smart Money Is Betting Big In LLY Options
July 05, 2024
Via
Benzinga
Copper, Gold Stocks Sparkle, Among 5 Leaders Near Buy Points
July 06, 2024
Southern Copper and Agnico Eagle surged above early entries.
Via
Investor's Business Daily
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
July 05, 2024
A study finds that GLP-1 treatments, including Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, significantly reduce the risk of ten obesity-related cancers in type 2 diabetes patients, highlighting...
Via
Benzinga
Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
July 05, 2024
However, small caps fell. Cooling economic data raised rate-cut hopes.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
July 04, 2024
Via
Benzinga
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
July 05, 2024
Could Zealand Pharma be a better option for growth-oriented investors?
Via
The Motley Fool
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street.
Via
InvestorPlace
7 High Priced Stocks That Would Benefit From a Stock Split
July 04, 2024
These companies are prime stock split candidates following moves from Nvidia and Broadcom along with other big names.
Via
InvestorPlace
Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
July 04, 2024
Investors shouldn't assume that all of the company's future growth is already priced into the stock's valuation.
Via
The Motley Fool
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
July 03, 2024
The study comes out of a Harvard teaching hospital based in Boston.
Via
Investor's Business Daily
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
The FDA has approved Eli Lilly's Kisunla (donanemab) for early symptomatic Alzheimer's disease. Kisunla, targeting amyloid plaques, shows a significant reduction in disease progression and may reduce...
Via
Benzinga
Exposures
Product Safety
'Other Bets' Startup Mineral Bites The Dust In Google Cost Cutting Move
July 03, 2024
Alphabet said it's shuttering agricultural startup Mineral, one of its "Other Bets" ventures, in a cost-cutting move for Google stock.
Via
Investor's Business Daily
Top 3 Health Care Stocks That May Crash This Quarter
July 03, 2024
Via
Benzinga
These 4 Vanguard ETFs Soared Over 20% in the First Half of 2024. Here's Which One Is Most Likely to Fly Even Higher.
July 03, 2024
These Vanguard ETFs have a lot in common.
Via
The Motley Fool
Topics
ETFs
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
July 03, 2024
The treatment is intended for adults in the early symptomatic stages of Alzheimer's disease.
Via
Benzinga
Exposures
Product Safety
Eli Lilly Receives FDA Approval For Its Alzheimer’s Drug Kinsula
July 03, 2024
Eli Lilly & Co received approval for its Alzheimer’s drug from the Food & Drug Administration on Tuesday. The development is significant as it expands treatment options for the neurological disorder...
Via
Talk Markets
Exposures
Product Safety
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
July 02, 2024
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AMZN Stock Outlook: Amazon’s Next Growth Wave Could Make Early Investors Rich
July 02, 2024
After effectively eliminating a threat from low-cost Chinese e-commerce websites and Amazon stock remains attractive.
Via
InvestorPlace
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
July 02, 2024
The company is on deck to rival Biogen and Eisai's Leqembi.
Via
Investor's Business Daily
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
July 02, 2024
We also talk about weight loss drugs and sleep apnea, and other stock market news.
Via
The Motley Fool
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
98
99
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.